Luxury electric car manufacturer Lucid (NASDAQ:LCID) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 123% year on year to $522.7 million. Its non-GAAP loss of $3.08 per share was 15.2% below analysts’ consensus estimates.
The US stock market staged a definitive recovery on Tuesday, February 24, 2026, as a duo of upbeat economic reports provided the "soft landing" narrative with much-needed oxygen. Following a bruising Monday session that saw major indices retreat on fears of trade volatility and cooling tech demand, the release of
The global financial landscape was thrust into a state of high-octane volatility this week as President Trump announced a transition to a 15% blanket global tariff, effectively circumventing a landmark Supreme Court ruling that had briefly threatened his "America First" trade agenda. The move, characterized by the administration as a
Maritime transportation company Matson (NYSE:MATX) reported Q4 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 4.3% year on year to $851.9 million. Its GAAP profit of $4.60 per share was 24.8% above analysts’ consensus estimates.
Netflix shares are ticking higher in extended trading on Tuesday after Warner Bros. Discovery provides an update on its merger agreement with the streaming giant.
Industrial and commercial distributor Global Industrial (NYSE:GIC) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 14.3% year on year to $345.6 million. Its GAAP profit of $0.38 per share was 18.8% above analysts’ consensus estimates.
Recreational vehicle (RV) and boat retailer Camping World (NYSE:CWH) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 2.6% year on year to $1.17 billion. Its non-GAAP loss of $0.73 per share was 53.9% below analysts’ consensus estimates.
Domain registrar and web services company GoDaddy (NYSE:GDDY) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 6.8% year on year to $1.27 billion. On the other hand, next quarter’s revenue guidance of $1.26 billion was less impressive, coming in 1.4% below analysts’ estimates. Its GAAP profit of $1.80 per share was 14% above analysts’ consensus estimates.
Home automation and security solutions provider Resideo Technologies (NYSE:REZI) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 2% year on year to $1.90 billion. On top of that, next quarter’s revenue guidance ($1.88 billion at the midpoint) was surprisingly good and 4.6% above what analysts were expecting. Its non-GAAP profit of $0.50 per share was 4.5% below analysts’ consensus estimates.
Biopharma company Corcept Therapeutics (NASDAQ:CORT) fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 11.1% year on year to $202.1 million. Its GAAP profit of $0.20 per share was 26.3% below analysts’ consensus estimates.
Medical device company Globus Medical (NYSE:GMED) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 25.7% year on year to $826.4 million. The company’s full-year revenue guidance of $3.2 billion at the midpoint came in 1.2% above analysts’ estimates. Its non-GAAP profit of $1.28 per share was 11% above analysts’ consensus estimates.
Composite decking and railing products manufacturer Trex Company (NYSE:TREX) beat Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 3.9% year on year to $161.1 million. The company’s full-year revenue guidance of $1.21 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $0.04 per share was significantly above analysts’ consensus estimates.
Healthcare solutions company Evolent Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 27.5% year on year to $468.7 million. The company’s full-year revenue guidance of $2.5 billion at the midpoint came in 4.9% above analysts’ estimates. Its non-GAAP profit of $0.08 per share was 62.7% above analysts’ consensus estimates.
Medical device company Merit Medical Systems (NASDAQ:MMSI) announced better-than-expected revenue in Q4 CY2025, with sales up 10.9% year on year to $393.9 million. The company’s full-year revenue guidance of $1.62 billion at the midpoint came in 0.9% above analysts’ estimates. Its non-GAAP profit of $0.93 per share was 2.5% below analysts’ consensus estimates.
Traffic solutions company Verra Mobility (NYSE:VRRM) announced better-than-expected revenue in Q4 CY2025, with sales up 16.4% year on year to $257.9 million. The company expects the full year’s revenue to be around $1.03 billion, close to analysts’ estimates. Its non-GAAP profit of $0.30 per share was 4.1% below analysts’ consensus estimates.
Professional services firm Huron Consulting Group (NASDAQ:HURN) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 10.7% year on year to $442 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $1.82 billion at the midpoint. Its non-GAAP profit of $2.17 per share was 11.3% above analysts’ consensus estimates.
MMCAP International increased its stake in NexGen Energy during the fourth quarter, deepening exposure to the company’s Rook I uranium project in Canada. As governments extend reactor lifespans and reconsider nuclear expansion, attention is turning to future uranium supply and how quickly projects like Rook I can begin production.
Infrastructure equipment supplier SPX Technologies (NYSE:SPXC) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 19.4% year on year to $637.3 million. The company’s full-year revenue guidance of $2.57 billion at the midpoint came in 3.8% above analysts’ estimates. Its non-GAAP profit of $1.88 per share was 0.7% above analysts’ consensus estimates.
Real estate technology company eXp World (NASDAQ:EXPI) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 8.5% year on year to $1.19 billion. Its GAAP loss of $0.08 per share was significantly below analysts’ consensus estimates.
Given its solid fundamentals, strong balance sheet, steady cash flow generation, and promising growth outlook, Whitecap Resources appears well-positioned to appeal to income-focused investors seeking both stability and long-term return potential.
Medical products company UFP Technologies (NASDAQ:UFPT) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 3.4% year on year to $148.9 million. Its non-GAAP profit of $2.44 per share was 9.2% above analysts’ consensus estimates.
